Last updated: August 6, 2025
Introduction
The patent KR102787188 pertains to a pharmaceutical invention filed within South Korea, a country renowned for its robust intellectual property (IP) regime and active patenting environment in the biopharmaceutical sector. Understanding its scope, claims, and competitive landscape is fundamental for stakeholders—including pharma companies, investors, and legal professionals—who seek to navigate the patent's implications effectively.
This analysis delves into the patent’s scope, examines its claims' specifics, reviews its positioning within the local and global patent landscape, and assesses strategic implications for patent holders and competitors.
Patent Overview and Background
KR102787188 was filed with the Korea Intellectual Property Rights Information Service (KIPRIS). While precise details, including publication and registration dates, specifics of the family members, and priority data, require access to official patent documents, typical structure and content of such patents can be inferred.
South Korean pharmaceutical patents often focus on novel compounds, formulations, methods of use, or manufacturing processes. Given recent trends and the company's strategic interests, KR102787188 most likely covers a novel chemical entity, a specific formulation, or a therapeutic use therein.
Scope of the Patent
Scope refers to the breadth of legal protection conferred by the patent, determining what activities infringe upon the patent rights. It hinges mainly upon the language and breadth of the claims.
-
Primary Claim Structure
The patent likely contains independent claims covering:
- A novel chemical compound or class thereof.
- A pharmaceutical composition comprising the compound.
- A specific therapeutic method of treatment utilizing the compound.
- A manufacturing process for the compound or composition.
-
Dependent Claims
Supporting claims probably specify variations of the compound (e.g., salts, esters), formulations, dosing regimens, or specific use indications, thereby strengthening the overall scope.
-
Claim Breadth
The scope depends heavily on whether claims are product-, process-, or use-based:
- Product claims typically offer broader protection linked to the chemical entity itself.
- Method claims focus on specific therapeutic applications.
- Use claims cover certain medical indications.
Given typical Korean patent strategies, a combination of these is used to maximize protection.
Claims Analysis
1. Chemical Composition or Compound Claims
The core claims probably involve a structurally novel molecule, possibly with specific substituents or stereochemistry that confer unique therapeutic properties.
-
The independent claim likely claims a compound with a particular structural formula, including optional substitutions.
-
The dependent claims refine this by specifying salt forms, pharmaceutical properties, or bioavailability enhancements.
2. Therapeutic Use Claims
Use-related claims could specify treatment of particular conditions—e.g., cancer, neurodegenerative diseases—aligning with the company's R&D focus.
3. Formulation and Manufacturing Claims
Claims may encompass specific formulations (e.g., sustained release), excipient combinations, or innovative synthesis routes.
4. Scope and Limitations
The breadth is constrained by prior art; the claims would aim to be broad enough to cover the core invention but narrow enough to survive novelty and inventive step requirements.
Patent Landscape in South Korea and Globally
The patent landscape surrounding KR102787188 is shaped by:
1. Prior Art Searches
An extensive prior art search indicates whether similar compounds or methods are patented locally or globally. Patent families filed in major jurisdictions (US, EU, China) in parallel directly impact the scope's strength and enforceability.
2. Competition and Patent Families
Competitors may have filed patent families covering similar chemical classes or indications. The strategic interplay involves patent filing timing, claim scope, and jurisdictions.
3. Patentability and Novelty
South Korean patent law demands novelty and inventive step. The patent likely distinguishes itself over existing patents via unique structural features, improved bioactivity, or therapeutic efficacy.
4. Existing Patent Thickets
In drugs targeting prominent classes (e.g., kinase inhibitors, monoclonal antibodies), overlapping patent rights create a "patent thicket," impacting freedom-to-operate (FTO). KR102787188 must carve out a clear niche to avoid infringing on overlapping rights.
5. Patent Expiry and Lapses
Typically, patents filed in the last 20-30 years are active. The patent's term (initially 20 years from filing date, extendable via regulatory exclusivities) influences its commercial utility.
Legal and Strategic Implications
-
For Innovators:
The patent's scope determines potential licensing, collaborations, or litigations. Broad claims can provide substantial market exclusivity but risk scuttling enforceability if challenged.
-
For Competitors:
Understanding the claims aids in designing around strategies—such as developing structurally distinct compounds or alternative methods—without infringing.
-
For Patent Holders:
Maximizing patent strength involves strategic claim drafting, supplementary protection certificates (SPCs), and filing continuations or divisional applications to extend scope.
Global Patent Landscape and Patent Family
It’s essential to compare KR102787188 with patent filings elsewhere.
-
Parallel filings:
The patent family likely extends to jurisdictions like the US (through continuations or divisionals), China, and Europe, forming a global patent landscape.
-
Compatibility with Patent Strategies:
Aligning claims with international patent standards (e.g., PCT routes) enhances global protection.
-
Patent Litigation and Challenges:
Similar compounds in other jurisdictions might have led to patent litigations, influencing enforcement and licensing potential in South Korea.
Conclusion
KR102787188’s scope primarily targets a novel chemical compound or therapeutic formulation with potentially broad claims supporting pharmaceutical use. Its strength hinges on claim drafting, prior art distinctions, and the alignment with global patent rights. In a competitive landscape marked by complex patent thickets in pharmaceutical sectors, strategic claim scope calibration is crucial for protecting innovations and navigating infringement risks.
Key Takeaways
- The patent likely covers a novel chemical entity, a specific formulation, and therapeutic method, with scope tailored to balance broad protection and patent defensibility.
- Comprehending its claims’ breadth aids stakeholders in assessing infringement risks and licensing opportunities.
- The global patent landscape influences its enforceability; parallel filings and prior art are critical considerations.
- Competitors must analyze claim specifics to develop legitimate around strategies while respecting the patent’s scope.
- Continued monitoring of patent family developments and potential challenges is vital for maintaining IP strength.
Frequently Asked Questions
1. What is the primary focus of patent KR102787188?
It likely protects a novel pharmaceutical compound, its formulation, or therapeutic use, contingent upon the inventors' claims.
2. How does the claim breadth impact market exclusivity?
Broader claims provide wider protection, deterring competitors but are more susceptible to validity challenges, while narrower claims are easier to defend but limit scope.
3. Can competitors design around this patent?
Yes. By developing structurally or functionally distinct compounds or alternative methods not encompassed by the claims, competitors can avoid infringement.
4. How does this patent fit into the global patent landscape?
If filed as part of an international strategy, it may be part of a broader patent family protecting similar inventions across key markets, affecting licensing and enforcement.
5. What are the potential strategic risks associated with this patent?
Risks include invalidation due to prior art, challenging claim validity, or patent infringement allegations in other jurisdictions, all impacting commercial plans.
References:
- Korea Intellectual Property Rights Information Service (KIPRIS). Patent KR102787188 documentation.
- World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT) filings for related families.
- [1] Patent Landscape Reports in South Korea's pharmaceutical sector.
- Industry analyses on drug patent strategies and litigations in Korea.
Note: Full detailed analysis requires access to actual patent claims and specifications, which are accessible through official patent databases such as KIPRIS.
